Bipolar Disorder

Overview

Bipolar disorder is a chronic neuropsychiatric condition characterized by recurrent episodes of mania (or hypomania) and depression, affecting approximately 1-2.4% of the global population. It carries significant morbidity — reduced life expectancy by 10-15 years, high suicide risk (~15-20x general population), and substantial metabolic comorbidity (obesity, type 2 diabetes, cardiovascular disease). The condition shares genetic risk loci, neuroinflammatory mechanisms, and microbiome signatures with schizophrenia and depression, suggesting a spectrum of related gut-brain axis disorders.

What distinguishes bipolar disorder in the metallomics-microbiome framework is the convergence of copper/zinc dysregulation, sex-specific fungal associations, and the largely unexplored microbiome effects of lithium — the oldest and most effective mood stabilizer.

Metallomic Signature

Copper/Zinc Ratio

Bipolar disorder shares the elevated Cu/Zn ratio seen in schizophrenia, though the pattern differs between mood states:

  • Manic episodes: Higher copper, increased ceruloplasmin (copper-carrying acute-phase protein), elevated oxidative stress markers
  • Depressive episodes: Lower zinc, impaired antioxidant defense (Cu/Zn-SOD activity reduced)
  • Euthymia (stable): Cu/Zn ratio may partially normalize but remains above healthy controls
  • Lithium effect: Lithium alters trace metal distribution, though the mechanism is poorly characterized

Iron

Iron dysregulation is reported in bipolar disorder, with elevated ferritin during manic episodes suggesting an inflammatory acute-phase response rather than true iron excess.

Microbiome Associations

Bacterial Dysbiosis

The bipolar gut microbiome shows alterations consistent with other neuropsychiatric conditions chrobak 2016 gut microbiome cns schizophrenia bipolar depression hashimoto 2023 host microbiome neuropsychiatric disorders:

  • Depleted: faecalibacterium prausnitzii (anti-inflammatory butyrate producer), bifidobacterium, lactobacillus
  • Enriched: enterobacteriaceae, certain Clostridia species
  • Functional: Reduced SCFA production, increased LPS biosynthesis, altered tryptophan metabolism
  • Mood-state dependent: Microbiome composition shifts between manic and depressive episodes, though longitudinal data are limited

Candida albicans: A Sex-Specific Signal

A striking finding: candida albicans IgG antibodies are significantly elevated in bipolar disorder patients with a history of mania, and this association is sex-specific severance 2016 candida albicans exposures sex specificity schizophrenia bipolar:

  • Women with bipolar disorder show strong association between Candida antibodies and cognitive deficits (especially working memory)
  • Men show a different pattern — Candida exposure associates with mania history but not cognitive domains
  • This sex specificity suggests interaction between fungal colonization, estrogen (metalloestrogens), and immune responses
  • candida albicans biofilms concentrate metals and may contribute to local metal dyshomeostasis in the gut

The Lithium-Microbiome Connection

Lithium remains the gold standard for bipolar disorder treatment, yet its microbiome effects are largely unexplored:

  • Lithium alters ion transport (competing with Na+, K+, Mg2+, Ca2+) throughout the body, including the gut epithelium
  • Lithium inhibits GSK-3beta, which regulates intestinal stem cell proliferation and gut barrier maintenance
  • Lithium's renal toxicity (common side effect) may create a secondary gut-kidney axis disruption
  • The narrow therapeutic index of lithium (0.6-1.2 mEq/L) means microbiome-mediated absorption variability could be clinically significant

Gut-Brain Axis in Bipolar Disorder

The bipolar gut-brain axis involves:

  1. Microbiome dysbiosis → reduced SCFA production → impaired gut barrier
  2. Barrier dysfunction → LPS translocation → systemic inflammation
  3. Neuroinflammation → microglial activation, altered neurotransmitter synthesis
  4. Tryptophan diversion → IDO/TDO activation shunts tryptophan from serotonin toward kynurenine pathway
  5. Kynurenine metabolites → NMDA receptor modulation → mood instability

Metal dysregulation amplifies this cascade: copper excess catalyzes ROS generation that damages the gut barrier, and zinc depletion impairs the immune regulation that normally prevents excessive neuroinflammation.

Associated Conditions

Bipolar disorder shares microbiome and metallomic features with several conditions in the WikiBiome knowledge graph:

ConditionShared FeaturesSignificance
schizophreniaCu/Zn dysregulation, Faecalibacterium depletion, Candida associationShared genetic risk (MHC locus); spectrum relationship
depressionSCFA depletion, tryptophan-kynurenine shift, Bifidobacterium lossDepressive episodes overlap; shared gut-brain mechanism
cardiovascular diseaseCopper elevation, systemic inflammation, endothelial dysfunction2-3x CVD risk in bipolar; shared inflammatory pathway
type 2 diabetesInsulin resistance, microbiome-mediated metabolic dysfunction3x T2D risk; shared SCFA depletion

Open Questions

  • Does lithium directly alter gut microbial composition, and if so, is this part of its therapeutic mechanism?
  • Can microbiome-targeted interventions reduce mood episode frequency or severity?
  • Is the Candida-mania association causal, and if so, would antifungal treatment improve outcomes?
  • Does the Cu/Zn ratio predict treatment response to lithium vs. anticonvulsants?
  • Can ketogenic diet interventions (being trialed; longhitano 2024 ketogenic diet schizophrenia bipolar rct protocol) work partly through microbiome-metal axis correction?

Key Studies

Cross-References

Related Articles